175 related articles for article (PubMed ID: 15181741)
21. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
22. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].
Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K
Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
[TBL] [Abstract][Full Text] [Related]
24. [Beta 2 microglobulin].
Clément F
Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
[TBL] [Abstract][Full Text] [Related]
25. [Serum ferritin as a possible tumor marker in malignant tumors of children].
Balitskaia OV; Chebotareva ED
Pediatriia; 1987; (2):64-7. PubMed ID: 3033595
[No Abstract] [Full Text] [Related]
26. Tumor necrosis factor in children with malignancies.
Saarinen UM; Koskelo EK; Teppo AM; Siimes MA
Cancer Res; 1990 Feb; 50(3):592-5. PubMed ID: 2297700
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
[TBL] [Abstract][Full Text] [Related]
28. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
29. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival.
Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S
Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578
[TBL] [Abstract][Full Text] [Related]
30. What's new in pediatric oncology? Epidemiology, treatment principles and prognosis in childhood malignancies.
Schellong G
Pathol Res Pract; 1985 Jan; 179(3):425-8. PubMed ID: 3885197
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
[TBL] [Abstract][Full Text] [Related]
32. [Clinical value of combined detection of LDH, TPS, CEA and beta2-MG in patients with non- Hodgkin's lymphoma].
Chen W; Luo RC; Fan WW; Ma SD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):227-8, 230. PubMed ID: 16503538
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of cell cycle in acute leukemias and non-Hodgkin's lymphomas in children].
Pituch-Noworolska A; Gawlicka M
Acta Haematol Pol; 1993; 24(4):365-71. PubMed ID: 8303983
[TBL] [Abstract][Full Text] [Related]
34. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
[TBL] [Abstract][Full Text] [Related]
35. [Beta 2 microglobulin in some hematologic neoplasms].
Rodríguez MA; Lira P; Foradori A; Grebe G
Rev Med Chil; 1989 Jun; 116(6):538-42. PubMed ID: 2664940
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
[TBL] [Abstract][Full Text] [Related]
37. G-CSF therapy and catheter-related Gram-positive sepsis increase serum IL-2 receptor α level and may falsely suggest a relapse in children with soft tissue sarcomas unless serum beta2-microglobulin, lactate dehydrogenase and C-reactive protein levels are determined concomitantly.
Bien E; Balcerska A; Niedzwiecki M; Krawczyk M; Rapala M; Trzonkowski P; Stepinski J
Cytokine; 2011 Sep; 55(3):347-52. PubMed ID: 21640605
[TBL] [Abstract][Full Text] [Related]
38. Serum Ca 125 levels in children with acute leukemia and lymphoma.
Birgen D; Ertem U; Duru F; Sahin G; Yüksek N; Bozkurt C; Karacan CD; Aksoy C
Leuk Lymphoma; 2005 Aug; 46(8):1177-81. PubMed ID: 16085559
[TBL] [Abstract][Full Text] [Related]
39. Iron deficiency anemia in children presenting with lymphoreticular malignancies and the effect of induction therapy.
Bhakhri BK; Vaidya PC; Trehan A; Marwaha RK; Garewal G
Pediatr Hematol Oncol; 2012 Mar; 29(2):148-53. PubMed ID: 22376018
[TBL] [Abstract][Full Text] [Related]
40. Serum intercellular adhesion molecule-1 in childhood malignancy.
Pui CH; Luo X; Evans W; Martin S; Rugg A; Wilimas J; Crist WM; Hudson M
Blood; 1993 Aug; 82(3):895-8. PubMed ID: 8101731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
